Double blinded clinical trial

Phase 3

Recruiting

• Conditions: brucellosis disease.; Brucellosis due to Brucella melitensis

• Registration Number: IRCT20180817040819N1
• Lead Sponsor: Sanandaj University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 25 February 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 280

Inclusion Criteria

All patients older than 18 years with brucellosis

Exclusion Criteria

pregnancy
history of sensitivity to drug
meningitis
endocarditis

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fever. Timepoint: 1 MONTH, 2 MONTH, SIX MONTH AFTER TREATMENT. Method of measurement: by thermometer and patient report.;Body pain. Timepoint: 1 MONTH, 2 MONTH, SIX MONTH AFTER TREATMENT. Method of measurement: patient report.;DIAPHORESIS. Timepoint: 1 MONTH, 2 MONTH, SIX MONTH AFTER TREATMENT. Method of measurement: patient report.;Diaphoresis. Timepoint: 1 MONTH, 2 MONTH, SIX MONTH AFTER TREATMENT. Method of measurement: patient report.;ESR. Timepoint: 1 MONTH, 2 MONTH, SIX MONTH AFTER TREATMENT. Method of measurement: by laborator.;CRP. Timepoint: 1 MONTH, 2 MONTH, SIX MONTH AFTER TREATMENT. Method of measurement: BY laboratoary.;WRIGHT. Timepoint: 1 MONTH, 2 MONTH, SIX MONTH AFTER TREATMENT. Method of measurement: agglutination test.;2ME. Timepoint: 1 MONTH, 2 MONTH, SIX MONTH AFTER TREATMENT. Method of measurement: agglutination.